National Centre for Pharmacoeconomics

National Centre for
Pharmacoeconomics

NCPE Ireland

Levofloxacin (Quinsair®) is indicated for the management of chronic pulmonary infections due to Pseudomonas aeruginosa in adult patients with Cystic Fibrosis.

 

Rapid Review

Commenced Completed Outcome
10/02/2016 01/03/2016 Full pharmacoeconomic evaluation recommended at the submitted price.

 

The HSE has approved reimbursement following confidential price negotiations.